All meetings are proceeding as scheuled and participants must be vaccinated and arrive with a recent negative COVID test to attend. Learn More

Neuroendocrine Cell Fate in Development and Cancer

March 10–13, 2022

Original Dates: April 22–25, 2021


Chaired By

 Cory Abate-Shen, PhD - Columbia University
 Julien Sage, PhD - Stanford University


Important Dates

 02/10/2022 -  Travel Form Due
 02/10/2022 -  Abstracts Due


Travel Agent Information

 Meeting #: Refer to your meeting email
 Hours: 8:00am – 8:00 pm EST M-F
 Domestic: 669-210-8002
 International : 623-516-6140


Venue Information

Asilomar Conference Grounds
800 Asilomar Avenue
Pacific Grove, CA 93950
831.372.8016

www.visitasilomar.com


About the Forbeck Foundation

 Forbeck Forum Information
 Travel Information
 General Program
 Frequently Asked Questions
 How to donate to WGFRF


Program Description

Neuroendocrine cancer is an umbrella term for a group of tumors in which cancer cells have the particularity of displaying traits similar to those of both nerve cells and hormone-producing cells. Neuroendocrine tumors can occur in many tissues and organs in the human body, including the lung, the pancreas, the prostate, or the skin. Some neuroendocrine tumors are very rare, others are more frequent; some are indolent, while others are extremely aggressive and fatal. Historically, neuroendocrine tumors have been studied and treated in the context of the specific site in which they were found. More recently, however, accumulating evidence has indicated that neuroendocrine tumors from various sites shared a number of important features, especially in terms of oncogenic drivers. A major goal of the meeting will thus be to discuss the biology and clinical aspects of neuroendocrine tumors to understand the differences and similarities between these tumors in different organs and tissues. We hope to arrive at a consensus about how to distinguish and define this group of tumors, and hopefully identify a framework to develop future therapeutic strategies that may help all patients with neuroendocrine cancer.


Travel Information

Travel forms are due 30 days prior to the start of the meeting to allow enough time to plan transportation.

The Monterey Regional Airport (MRY) is the preferred airport as it is only 20 minutes from the meeting location.

  • Arrivals - Thursday at 1 PM, 3 PM and 5 PM
  • Departures - Sunday at 10 AM, 12 PM and 2 PM

San Francisco International Airport (SFO) is 2 hours from the meeting location without traffic. The Foundation can only accommodate 1 pick up per day at San Francisco. If you absolutely must fly into San Francisco (ie: International Flights) the Foundation will have the following pick up times:

  • Arrivals - Thursday at 3 PM
  • Departures - Sunday at 10 AM

Submit Travel Form

Abstracts

Abstracts are due 30 days prior to the start of the meeting to allow enough time to prepare the meeting book.

Abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.

Submit Abstract

Forum Participants

Participant Institution
Cory Abate-Shen, PhD Columbia University Irving Medical Center
Rod Bremner Mount Sinai Hospital
Andrea Califano, PhD Columbia University
James DeCaprio, MD Dana-Farber Cancer Institute, Harvard Medical School
Andrew Goldstein, PhD University of California Los Angeles
Jane Johnson, PhD UT Southwestern Medical Center
Mark Krasnow, MD, PhD Howard Hughes Medical Institute
Christin Kuo Stanford University
David McConkey, PhD Johns Hopkins Medicine
Peter Nelson, MD Fred Hutchinson Cancer Research Center
Trudy Oliver, PhD University of Utah & Huntsman Cancer Institute
Mark Rubin, PhD University of Bern
Julien Sage, PhD Stanford University
Michael Shen, PhD Columbia University
Xin Sun, PhD University of California San Diego

Forum Scholars

Scholar Institution
Eric Gardner, PhD Weill Cornell Medicine
Catherine Meador, MD Massachusetts General Hospital Cancer Center
Nitin Roper, MD National Cancer Institute

For more than 35 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!